Peripheral blood biomarkers correlate with outcomes in advanced non-small cell lung Cancer patients treated with anti-PD-1 antibodies

BACKGROUND: Anti-programmed cell death 1 (PD-1) antibodies have demonstrated improved overall survival (OS) and progression-free survival (PFS) in a subset of patients with metastatic or locally advanced non-small cell lung cancer (NSCLC). To date, no blood biomarkers have been identified in NSCLC t...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Immunother Cancer
Main Authors: Soyano, Aixa E., Dholaria, Bhagirathbhai, Marin-Acevedo, Julian A., Diehl, Nancy, Hodge, David, Luo, Yan, Manochakian, Rami, Chumsri, Saranya, Adjei, Alex, Knutson, Keith L., Lou, Yanyan
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2018
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6251165/
https://ncbi.nlm.nih.gov/pubmed/30470260
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-018-0447-2
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker